Outset Medical, Inc. (OM) — Financial statements
Income statement, balance sheet, and cash flow for Outset Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 119↑5.1% | 114↓12.8% | 130↑13.0% | 115↑12.4% | 103 | |
| Cost of Revenue | 73↓3.2% | 75↓25.9% | 101↑3.9% | 98↑2.7% | 95 | |
| Gross Profit | 47↑21.2% | 39↑33.0% | 29↑62.6% | 18↑134.4% | 8 | |
| Operating Expenses | ||||||
| R&D Expenses | 21↓44.7% | 38↓33.0% | 57↑17.3% | 49↑33.0% | 37 | |
| General & Administrative Expenses | 38↓13.0% | 43↓3.8% | 45↑11.6% | 41↑11.6% | 36 | |
| Selling & Marketing Expenses | 54↓22.4% | 70↓27.2% | 96↑7.5% | 89↑37.5% | 65 | |
| SG&A Expenses | 92↓18.8% | 114↓19.7% | 141↑8.8% | 130↑28.2% | 101 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 113↓25.3% | 152↓23.6% | 199↑11.1% | 179↑29.5% | 138 | |
| Total Costs & Expenses | 186↓18.0% | 227↓24.3% | 300↑8.6% | 276↑18.6% | 233 | |
| Operating Results | ||||||
| Operating Income | -67↑41.2% | -113↑33.2% | -170↓5.4% | -161↓23.4% | -131 | |
| Depreciation & Amortization | 4↓24.2% | 6↓1.4% | 6↓7.5% | 6↑21.7% | 5 | |
| EBITDA | -62↑36.3% | -98↑36.4% | -154↓0.6% | -153↓22.4% | -125 | |
| EBIT | -67↑38.1% | -108↑32.4% | -160↓0.3% | -159↓22.4% | -130 | |
| Interest & Other Income | ||||||
| Net Interest Income | -7↑53.6% | -14↓463.5% | -3↓810.5% | -0.28↑77.4% | -1 | |
| Interest Income | 7↓24.1% | 10↓4.0% | 10↑209.1% | 3↑560.8% | 0.50 | |
| Interest Expense | 14↓41.6% | 24↑88.3% | 13↑255.4% | 4↑107.9% | 2 | |
| Non-Operating Income | 0.01↑100.1% | -6↑45.4% | -10↓428.6% | -2↓286.3% | -0.50 | |
| Other Income / Expenses | -14↓0.8% | -14↓463.5% | -3↓52.5% | -2↓34.9% | -1 | |
| Income Before Tax | -81↑36.5% | -127↑26.0% | -172↓5.9% | -163↓23.5% | -132 | |
| Income Tax Expense | 0.72↑46.2% | 0.49↓6.1% | 0.52↑77.3% | 0.30↑48.2% | 0.20 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -82↑36.2% | -128↑25.9% | -173↓6.0% | -163↓23.5% | -132 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -82↑36.2% | -128↑25.9% | -173↓6.0% | -163↓23.5% | -132 | |
| Bottom-Line Net Income | -82↑36.2% | -128↑25.9% | -173↓6.0% | -163↓23.5% | -132 | |
| EPS (Basic) | -5.37↑85.5% | -36.95↑29.3% | -52.27↓3.0% | -50.75↓16.9% | -43.41 | |
| EPS (Diluted) | -5.37↑85.5% | -36.95↑29.3% | -52.27↓3.0% | -50.75↓16.9% | -43.41 | |
| Weighted Average Shares | 15↑339.2% | 3↑4.8% | 3↑3.0% | 3↑5.6% | 3 | |
| Weighted Average Diluted Shares | 15↑339.2% | 3↑4.8% | 3↑3.0% | 3↑5.6% | 3 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.